Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers

被引:414
|
作者
Rege, BD
Kao, JPY
Polli, JE [1 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA
关键词
nonionic surfactants; transporters; P-glycoprotein (P-gp); human intestinal peptide transporter (hPepT-1); monocarboxylic acid transporter (MCT);
D O I
10.1016/S0928-0987(02)00055-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objectives of this study were (1) to investigate the transporter inhibition activity of three nonionic surfactants on P-glycoprotein, the human intestinal peptide transporter, and the monocarboxylic acid transporter in Caco-2 cell monolayers, and (2) to evaluate the role of membrane fluidity and protein kinase C in surfactant-induced transporter inhibition. All three surfactants inhibited P-glycoprotein (P-gp). Over a range from 0 to 1 mM, Tween 80 and Cremophor EL increased apical-to-basolateral permeability (AP-BL) and decreased basolateral-to-apical (BL-AP) permeability of the P-gp substrate rhodamine 123. Vitamin E TPGS's effect was equally large, but essentially only reduced the BL-AP permeability of rhodamine 123, and did so at a vitamin E TPGS concentration of only 0.025 mM. These P-gp inhibition effects would appear to be related to these excipients' modulation of membrane fluidity, where Tween 80 and Cremophor EL fluidized cell lipid bilayers, while vitamin E TPGS rigidized lipid bilayers. However, among the three surfactants, only Tween 80 inhibited the peptide transporter, as measured by glycyl sarcosine permeability. Likewise, only Cremophor EL inhibited the monocarboxylic acid transporter, as measured by benzoic acid permeability. Nevertheless, at least one of these three surfactants inhibited each P-gp, the human intestinal peptide transporter, and the monocarboxylic acid transporter. A common functional feature of these three surfactants was their ability to modulate fluidity, although results indicate that even strong membrane fluidity modulation alone was not sufficient to reduce transporter activity. N-octyl glucoside, a nonionic surfactant that did not modulate membrane fluidity, did not affect transporter functioning. Protein kinase C inhibitors failed to affect rhodamine 123 and glycyl sarcosine permeability, suggesting protein kinase C inhibition was not the mechanism of transporter inhibition. These results suggest that surfactants can inhibit multiple transporters but that changes in membrane fluidity may not be a generalized mechanism to reduce transporter activity. (C) 2002 Elsevier Science B V All rights reserved.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 25 条
  • [21] Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines
    Mukkavilli, Rao
    Jadhav, Gajanan
    Vangala, Subrahmanyam
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (14) : 1151 - 1158
  • [22] Anti-Inflammatory Effects of a Novel Acetonitrile-Water Extract of Lens Culinaris against LPS-Induced Damage in Caco-2 Cells
    Maqoud, Fatima
    Orlando, Antonella
    Tricarico, Domenico
    Antonacci, Marina
    Di Turi, Annamaria
    Giannelli, Gianluigi
    Russo, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [23] Boosting of HIV Protease Inhibitors by Ritonavir in the Intestine: The Relative Role of Cytochrome P450 and P-Glycoprotein Inhibition Based on Caco-2 Monolayers versus In Situ Intestinal Perfusion in Mice
    Holmstock, Nico
    Annaert, Pieter
    Augustijns, Patrick
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1473 - 1477
  • [24] Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2′,7′-Dichloroflourescein Disposition in Caco-2 Cells
    Drennen, Callie
    Gorse, Erin
    Stratford, Robert E., Jr.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (04) : 1194 - 1203
  • [25] Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices
    Huliciak, Martin
    Vokral, Ivan
    Holas, Ondrej
    Martinec, Ondrej
    Staud, Frantisek
    Cerveny, Lukas
    PHARMACEUTICALS, 2022, 15 (02)